Cipla becomes 2nd firm to enter tie-up with Gilead to make remdesivir in India MD Bureau13 May 2020 9:23 AM ISTCipla will be permitted to manufacture the active pharmaceutical ingredient (API) and finished product, and market it in 127 countries including India...
Healthier eating behaviors early in life reduce risk of obesity and CVD later: AHA Dr. Kamal Kant Kohli12 May 2020 4:45 PM ISTDALLAS — American Heart Association has issued a new scientific statement about"Caregiver Influences on Eating Behaviors in Young Children," that has...
Glenmark begins Phase 3 Clinical Trials on Antiviral Favipiravir for coronavirus in India Ruchika Sharma12 May 2020 12:57 PM ISTFavipiravir has demonstrated activity against influenza viruses and has been approved in Japan for the treatment of novel influenza virus infections
Glenmark Pharmaceuticals launches 3-in-1 inhaler therapy AIRZ-FF for COPD in India Ruchika Sharma11 May 2020 1:07 PM ISTMumbai: Glenmark Pharmaceuticals Ltd. announced the launch of a Single Inhaler Triple Therapy AIRZ-FF - a combination of two bronchodilators,...
Telangana: Bulk drug manufacturers operating at 50% capacity despite exemption MD Bureau10 May 2020 12:11 PM ISTHyderabad: Despite being exempted from lockdown, the bulk drug manufacturers in Telangana are operating at only 50 per cent of their capacity,...
Priced at Rs 5995 for weekly therapy, Zydus Cadila Launches affordable prostate cancer drug Obnyx in India Ruchika Sharma9 May 2020 12:00 PM ISTIn a step that can significantly reduce treatment costs by almost 70%, the drug is priced at Rs 5995 (weekly therapy) reducing the monthly treatment...
Drug Discovery Turns Fatal: Chennai based pharmacist dies after consuming experimental drug MD Bureau8 May 2020 9:28 PM ISTChennai: In a tragic incident where a drug discovery turned fatal, a senior official of the city-based Sujatha Bio-Tech died after consuming a...
Biocon gets EIR for Small Molecules API Manufacturing Facility for Pre -Approval, GMP USFDA Inspection Ruchika Sharma8 May 2020 2:29 PM ISTBengaluru: Biocon has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) for the Pre-Approval and GMP...
Bharat Biotech to lead project to develop human antibodies for COVID-19 MD Bureau8 May 2020 12:36 PM IST"We are fast-tracking the development process, to make the antibodies available within the next 6 months and thus improve the treatment efficacy,"...
Cipla loses Cancer Drug patent battle to Amgen in US court Ruchika Sharma7 May 2020 1:58 PM ISTUS: In a major setback to drug major Cipla, the company has lost the patent infringement battle against Amgen Inc over the generic version of...
Zydus Cadila seeks DCGI approval for clinical trial of hepatitis drug PegiHep in COVID-19 Ruchika Sharma6 May 2020 11:51 AM ISTPegylated Interferon Alpha-2b has been used in the treatment of COVID-19 in China and Cuba and is a part of the treatment guidelines of the Chinese...
FDA approves dapagliflozin for heart failure with reduced ejection fraction Dr. Kamal Kant Kohli6 May 2020 9:52 AM ISTThe U.S. Food and Drug Administration has approved Farxiga (dapagliflozin) oral tablets for adults with heart failure with reduced ejection fraction...
